PsyPost on MSN

Different forms of intelligence show unique genetic links to psychiatric conditions

A massive new study reveals that different types of intelligence share distinct genetic links with various psychiatric ...

AI didn’t break higher education—It exposed the credential trap

As tuition soars past crisis levels and AI reshapes the classroom, students are rationally optimizing for diplomas over ...
Stars Insider on MSN

Chocolate chronicles: A history of the cacao bean

There are few things as sensuous and delicious as chocolate. Whether it is a small piece after dinner, or a chocolate dessert ...
Connaught Telegraph

Data centre electricity consumption up 10%, CSO says

The metered electricity consumption by data centres rose by 10 per cent last year, now accounting for almost a quarter of all ...
PA Media on MSN

Budget must prioritise fully public-funded childcare – National Women’s Council

The group represents almost 200 women’s organisations across the island of Ireland.

Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been ...

Axsome Therapeutics, Inc.: Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)

The FOCUS-2 trial in children complements the recently announced FOCUS-3 trial in adolescents with ADHD NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharm ...